SRXH SRX Global Inc.
Company Analysis
Latest News
🟢 SRX Global is trading 10.45% up today amid renewed technology-sector and AI-chip optimism
SRX Global is trading at $1.79, up +10.45%, most consistently with renewed technology-sector and AI-chip optimism. - No fresh company-specific announcement...
🟢 SRX Global is trading 8% up today on a broader technology-sector rally
SRX Global is trading 8% up at $1.75, most consistent with a broader technology-sector rally and renewed AI-chip optimism. - No new company-specific...
🔴 SRX Global is trading 5.6% down today; catalyst remains unclear
SRX Global is trading at $1.61 (-5.56%) with the catalyst unclear. - No new company-specific announcement dated September 16, 2026 was found; the latest...
🟢 SRX Global is trading 5.6% up today after amendment allowing repurchase plan continuation
SRX Global is trading 5.6% up at $1.68 after investors continued responding to the September 8, 2026 amendment permitting the company’s existing repurchase...
🟢 SRX Global is trading 5% up today after amendment allows buyback continuation
SRX Global is trading 5.21% up now at $1.64 as investors continue responding to the September 8 amendment allowing its existing repurchase plan to continue. -...
🟢 SRX Global is trading 5% up today after repurchase plan amendment
SRX Global is trading 5.29% up at $1.59 after announcing an amendment permitting its existing repurchase plan to continue. - Purchases may total up to 10...
🟢 SRX Global is trading 5.3% up
SRX Global is trading at $1.59, +5.29%, with the catalyst still uncertain. - No verified September 8, 2026 company-specific announcement was found explaining...
SRX Global's Portfolio Company ARMR Sciences Reports Positive Anti-Fentanyl Vaccine Data
SRX Global Inc. provided an update on ARMR Sciences, its portfolio company. ARMR Sciences is developing ARMR-100, a clinical-stage anti-fentanyl vaccine...
SRX Global Provides Up to $11.7M in Secured Financing to CERo Therapeutics
SRX Global Inc. has entered into a secured financing transaction with CERo Therapeutics Holdings, Inc. (CERO), providing up to $11.7 million in total funding....
SRXH Enters $2.86M Private Placement for Series C Preferred Stock via Note Exchange
SRX Global Inc. entered into a securities purchase agreement with accredited investors to issue 3,579 shares of its new Series C convertible preferred stock....
🟢 SRX Global is trading 5.1% up in pre-market after Nvidia’s earnings-driven rally
SRX Global is trading 5.1% up at $1.84 after broader technology sentiment strengthened following Nvidia’s earnings-driven rally. - No new company-specific...
🟢 SRX Global is trading 6.25% up today amid stronger technology sentiment and AI optimism
SRX Global is trading 6.25% up at $1.96, with the rally apparently aligned with stronger technology sentiment, Nvidia’s earnings and broader AI optimism. - No...
🟢 SRX Global is trading 6.35% up today after revenue rose 27% to $3.4 million
SRX Global is trading at $1.93, up 6.35%, after third-quarter revenue grew 27% to $3.4 million and its operating loss sharply narrowed. - NAV reached $3.22...
🟢 SRX Global is trading 5% up today after Q3 earnings showed 27% sales growth
SRX Global is trading 5.03% up now at $1.88 after fiscal third-quarter results highlighted 27% year-over-year sales growth to $3.4 million and sharply narrower...
🔴 SRX Global is trading 6.35% down today as technology stocks retreat amid geopolitical tensions
SRX Global is trading 6.35% down at $1.77 as technology stocks and broader markets retreat amid geopolitical tensions and surging bond yields. - No August 18,...
🟢 SRX Global is trading 5.5% up today after fiscal third-quarter results showed 27% revenue growth
SRX Global is trading 5.46% up at $1.93 on August 14, 2026, following fiscal third-quarter results released August 13, with revenue rising 27% year over year...
🔴 SRX Global is trading 6.25% down today; catalyst remains unclear
SRX Global is trading at $1.73 (-6.25%) as the catalyst for the August 13 decline remains unclear. - No confirmed company-specific announcement or earnings...
SRX Global Inc. Fiscal Q3 2026 Earnings Preview: What Analysts Expect on August 13, 2026
SRX Global Inc. (SRXH) is scheduled to report its fiscal third quarter 2026 results on August 13, 2026, with limited analyst coverage projecting an EPS of...
🟢 SRX Global is trading 5.49% up today ahead of August 13 fiscal third-quarter 2026 results
SRX Global is trading 5.49% up now at $1.82 after continuing a recent rally; no fresh company-specific announcement explaining the August 11, 2026 move was...
🟢 SRX Global is trading 10.38% up today after weak July payrolls reduced Fed rate-hike expectations
SRX Global is trading at $1.75 (+10.38%) after unexpectedly weak July employment data reduced expectations of an imminent Federal Reserve rate hike. - U.S....